$MGNI
Magnite Inc

2014 Q4 Form 10-Q Financial Statement

#000159597414000010 Filed on October 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $41.83M $32.17M $20.06M
YoY Change 48.7% 60.32%
Cost Of Revenue $6.300M $5.144M $4.181M
YoY Change 51.81% 23.03%
Gross Profit $35.53M $27.02M $15.88M
YoY Change 48.1% 70.14%
Gross Profit Margin 84.94% 84.01% 79.16%
Selling, General & Admin $27.61M $26.70M $14.01M
YoY Change 62.32% 90.58%
% of Gross Profit 77.71% 98.8% 88.2%
Research & Development $7.680M $5.766M $4.823M
YoY Change 69.16% 19.55%
% of Gross Profit 21.62% 21.34% 30.37%
Depreciation & Amortization $4.400M $3.070M $2.030M
YoY Change 90.48% 51.23% -57.8%
% of Gross Profit 12.38% 11.36% 12.78%
Operating Expenses $35.28M $32.46M $18.83M
YoY Change 63.71% 72.39%
Operating Profit $250.0K -$5.442M -$2.949M
YoY Change -89.75% 84.54%
Interest Expense $1.210M $800.0K -$830.0K
YoY Change -436.11% -196.39%
% of Operating Profit 484.0%
Other Income/Expense, Net $0.00 $803.0K -$1.922M
YoY Change -100.0% -141.78%
Pretax Income $1.460M -$4.639M -$4.871M
YoY Change 7200.0% -4.76%
Income Tax $30.00K -$17.00K $74.00K
% Of Pretax Income 2.05%
Net Earnings $1.430M -$4.622M -$4.945M
YoY Change -3675.0% -6.53%
Net Earnings / Revenue 3.42% -14.37% -24.65%
Basic Earnings Per Share
Diluted Earnings Per Share $41.47K -$137.2K -$142.6K
COMMON SHARES
Basic Shares Outstanding 35.96M shares 35.87M shares 11.54M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $97.20M $104.1M $21.00M
YoY Change 224.0% 395.71%
Cash & Equivalents $97.20M $104.1M $20.96M
Short-Term Investments
Other Short-Term Assets $7.500M $6.300M $3.300M
YoY Change 82.93% 90.91%
Inventory
Prepaid Expenses
Receivables $133.3M $99.91M $69.60M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $238.0M $210.3M $93.90M
YoY Change 84.74% 124.0%
LONG-TERM ASSETS
Property, Plant & Equipment $15.20M $14.11M $8.500M
YoY Change 74.43% 66.01%
Goodwill $16.29M $1.491M
YoY Change 992.56%
Intangibles $14.09M $180.0K
YoY Change 2662.75%
Long-Term Investments
YoY Change
Other Assets $1.427M $1.425M $2.100M
YoY Change -54.71% -32.14%
Total Long-Term Assets $58.50M $28.43M $19.20M
YoY Change 177.69% 48.06%
TOTAL ASSETS
Total Short-Term Assets $238.0M $210.3M $93.90M
Total Long-Term Assets $58.50M $28.43M $19.20M
Total Assets $296.5M $238.8M $113.1M
YoY Change 97.8% 111.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $143.7M $121.1M $84.00M
YoY Change 24.74% 44.17%
Accrued Expenses $7.300M $6.900M $4.000M
YoY Change 46.0% 72.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $200.0K $400.0K
YoY Change -66.67% -50.0%
Total Short-Term Liabilities $154.4M $130.3M $90.90M
YoY Change 25.14% 43.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $7.300M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.272M $1.674M $1.000M
YoY Change 27.71% 67.4%
Total Long-Term Liabilities $1.272M $1.674M $8.300M
YoY Change 27.71% -79.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $154.4M $130.3M $90.90M
Total Long-Term Liabilities $1.272M $1.674M $8.300M
Total Liabilities $167.7M $131.9M $99.20M
YoY Change 25.43% 33.01%
SHAREHOLDERS EQUITY
Retained Earnings -$80.71M -$82.14M
YoY Change 30.1%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $128.8M $106.8M $14.00M
YoY Change
Total Liabilities & Shareholders Equity $296.5M $238.8M $113.1M
YoY Change 97.8% 111.11%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $1.430M -$4.622M -$4.945M
YoY Change -3675.0% -6.53%
Depreciation, Depletion And Amortization $4.400M $3.070M $2.030M
YoY Change 90.48% 51.23% -57.8%
Cash From Operating Activities $1.400M $4.700M -$1.400M
YoY Change -88.62% -435.71% -125.36%
INVESTING ACTIVITIES
Capital Expenditures -$4.310M -$6.210M -$4.280M
YoY Change 49.65% 45.09% -3.17%
Acquisitions
YoY Change
Other Investing Activities -$3.740M $0.00 $50.00K
YoY Change -7580.0% -100.0% -102.14%
Cash From Investing Activities -$8.040M -$6.210M -$4.230M
YoY Change 184.1% 46.81% -37.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -80.00K -60.00K -40.00K
YoY Change -78.38% 50.0% -96.43%
NET CHANGE
Cash From Operating Activities 1.400M 4.700M -1.400M
Cash From Investing Activities -8.040M -6.210M -4.230M
Cash From Financing Activities -80.00K -60.00K -40.00K
Net Change In Cash -6.720M -1.570M -5.670M
YoY Change -173.85% -72.31% 140.25%
FREE CASH FLOW
Cash From Operating Activities $1.400M $4.700M -$1.400M
Capital Expenditures -$4.310M -$6.210M -$4.280M
Free Cash Flow $5.710M $10.91M $2.880M
YoY Change -62.38% 278.82% -71.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
120198000 USD
CY2014Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
127982000 USD
CY2013Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4136000 USD
CY2014Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3490000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
99913000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94722000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
62000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
96000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
188899000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25532000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17219000 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
200000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1549000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16727000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7150000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4567000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10732000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23124000 shares
CY2013Q4 us-gaap Assets
Assets
149887000 USD
CY2014Q3 us-gaap Assets
Assets
238766000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
128819000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
210338000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1124000 USD
CY2013Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
393000 USD
CY2014Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
157000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104089000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29956000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8123000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
732000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1356000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6133000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-199000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.81
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
12000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.08
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20959000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21616000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-657000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
74133000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
73380126 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80608856 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35880000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11855000 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35880000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11855000 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4882000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9203000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20136000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4693000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
52571000 USD
us-gaap Cost Of Revenue
CostOfRevenue
11212000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
4181000 USD
us-gaap Cost Of Revenue
CostOfRevenue
14456000 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
5144000 USD
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
23012000 USD
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
37607000 USD
us-gaap Costs And Expenses
CostsAndExpenses
102490000 USD
us-gaap Costs And Expenses
CostsAndExpenses
62014000 USD
CY2013Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4181000 USD
CY2014Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
157000 USD
CY2014Q3 us-gaap Debt Current
DebtCurrent
157000 USD
CY2013Q4 us-gaap Debt Current
DebtCurrent
288000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-43000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
CY2014Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
3500000 USD
CY2014Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2067000 USD
CY2013Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1090000 USD
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
99000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
5000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4984000 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6877000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
492000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
103000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-413000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-663000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-104000 USD
CY2013Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-763000 USD
CY2014Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
826000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42130000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7603000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15157000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17963000 USD
CY2014Q3 us-gaap Goodwill
Goodwill
1491000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
1491000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9025000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4639000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19957000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4871000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
187000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9115000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6909000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5301000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2504000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-906000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
976000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
796000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1936000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1200000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-100000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
510000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
238766000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
149887000 USD
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
180000 USD
CY2014Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-23000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-94000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-229000 USD
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-69000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4600000 USD
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1300000 USD
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3500000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
133727000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
131946000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
123387000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
130272000 USD
CY2014Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2013Q4 us-gaap Line Of Credit
LineOfCredit
3788000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3893000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-428000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83865000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15083000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9025000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8791000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5252000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9212000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-4945000 USD
us-gaap Net Income Loss
NetIncomeLoss
-20102000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-4622000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12386000 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6015000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21218000 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4622000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2709000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-930000 USD
us-gaap Revenues
Revenues
55698000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
803000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1922000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15041000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14072000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4823000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-19027000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2949000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6316000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5442000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1425000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3151000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-34000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
9000 USD
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
63000 USD
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-71000 USD
CY2014Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2133000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2901000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1674000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
996000 USD
us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
803000 USD
us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3037000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8564000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5441000 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2384000 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6619000 USD
CY2013Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1070000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1116000 USD
CY2014Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3174000 USD
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4141000 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6336000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
89733000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
478000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1194000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14111000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8712000 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
906000 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
4025000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5766000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82141000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62039000 USD
CY2013Q3 us-gaap Revenues
Revenues
20063000 USD
us-gaap Revenues
Revenues
83463000 USD
CY2014Q3 us-gaap Revenues
Revenues
32165000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11540000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30863000 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6405000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18767000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
16727000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4567000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
12000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2188000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
2200000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3930000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
486000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
8.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1137000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.33
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8246000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8360000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.13
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.43
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7597000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.26
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.93
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.24
CY2014Q2 us-gaap Share Price
SharePrice
15.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y3M8D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M25D
CY2013Q4 rubi Accounts Payable Seller Current
AccountsPayableSellerCurrent
111078000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y11M2D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
765000 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
52571000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
86200000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1194000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
106820000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-36411000 USD
CY2013Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
52571000 USD
CY2014Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;text-align:left;padding-left:36px;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these estimates. </font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management evaluates its estimates, primarily those related to: (i)&#160;revenue recognition criteria, including the determination of revenue reporting as net versus gross in the Company&#8217;s revenue arrangements, (ii)&#160;accounts receivable and allowances for doubtful accounts, (iii)&#160;the useful lives of intangible assets and property and equipment, (iv)&#160;valuation of long-lived assets and their recoverability, including goodwill, (v)&#160;the realization of tax assets and estimates of tax liabilities, (vi)&#160;the valuation of common and preferred stock and preferred stock warrants prior to the Company</font><font style="font-family:inherit;font-size:11pt;">&#8217;</font><font style="font-family:inherit;font-size:10pt;">s IPO, (vii)&#160;assumptions used in valuation models to determine the fair value of stock-based awards, (viii)&#160;fair value of financial instruments, (ix)&#160;the recognition and disclosure of contingent liabilities, and (x)&#160;the assumptions used in calculating the valuation of acquired assets and business combinations. These estimates are based on historical data and experience, as well as various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Estimates relating to the valuation of stock and business acquisitions require the selection of appropriate valuation methodologies and models, and significant judgment in evaluating ranges of assumptions and financial inputs. Actual results may differ materially from those estimates under different assumptions or circumstances.</font></div></div>
CY2014Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5451000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26130000 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11544000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11433000 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33673000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11503000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27746000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11544000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35865000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
0 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
2192000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1616000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
70000 shares
CY2013Q4 rubi Accounts Payable Rightto Offset Current
AccountsPayableRighttoOffsetCurrent
900000 USD
CY2014Q3 rubi Accounts Payable Rightto Offset Current
AccountsPayableRighttoOffsetCurrent
700000 USD
CY2014Q3 rubi Internal Use Software Development Costs Net
InternalUseSoftwareDevelopmentCostsNet
11221000 USD
CY2014Q3 rubi Accounts Payable Seller Current
AccountsPayableSellerCurrent
117615000 USD
rubi Acquisition Fee Percentageof Consideration Due
AcquisitionFeePercentageofConsiderationDue
0.025
CY2013Q4 rubi Internal Use Software Development Costs Net
InternalUseSoftwareDevelopmentCostsNet
7204000 USD
CY2014Q3 rubi Operating Leases Entered Since Prior Year End Future Minimum Payments Due
OperatingLeasesEnteredSincePriorYearEndFutureMinimumPaymentsDue
6500000 USD
CY2014Q2 rubi Proccedsfrom Issuance Initial Public Offering Netof Offering Costs
ProccedsfromIssuanceInitialPublicOfferingNetofOfferingCosts
86200000 USD
rubi Reclassificationofdeferredofferingcoststoadditionalpaidincapital
Reclassificationofdeferredofferingcoststoadditionalpaidincapital
0 USD
rubi Reclassificationofdeferredofferingcoststoadditionalpaidincapital
Reclassificationofdeferredofferingcoststoadditionalpaidincapital
3533000 USD
rubi Reclassificationofpreferredstockwarrantliabilitiestoadditionalpaidincapital
Reclassificationofpreferredstockwarrantliabilitiestoadditionalpaidincapital
6183000 USD
rubi Reclassificationofpreferredstockwarrantliabilitiestoadditionalpaidincapital
Reclassificationofpreferredstockwarrantliabilitiestoadditionalpaidincapital
0 USD
rubi Stock Issued During Period Value Stock Warrants Net Exercised
StockIssuedDuringPeriodValueStockWarrantsNetExercised
5983000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001595974
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35955841 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
RUBICON PROJECT, INC.

Files In Submission

Name View Source Status
0001595974-14-000010-index-headers.html Edgar Link pending
0001595974-14-000010-index.html Edgar Link pending
0001595974-14-000010.txt Edgar Link pending
0001595974-14-000010-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rubi-20140930.xml Edgar Link completed
rubi-20140930.xsd Edgar Link pending
rubi-20140930_cal.xml Edgar Link unprocessable
rubi-20140930_def.xml Edgar Link unprocessable
rubi-20140930_lab.xml Edgar Link unprocessable
rubi-20140930_pre.xml Edgar Link unprocessable
rubi10q9-30x2014.htm Edgar Link pending
rubiex3119-30x2014.htm Edgar Link pending
rubiex3129-30x2014.htm Edgar Link pending
rubiex3219-30x2014.htm Edgar Link pending
Show.js Edgar Link pending